Breast: ROSETTA Breast-01
Trial ID
07173751
Trial Sponsor
BioNTech SE
A Phase III, multisite, randomized, double-blind trial of BNT327 in combination with chemotherapy versus placebo with chemotherapy in patients with previously untreated locally recurrent inoperable or metastatic TNBC whose tumor PD-L1 status is considered negative